Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse Schizophrenia”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Post-approval studies (Phase 4)Study completedNCT00253110
What this trial is testing

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 396
Not applicableNot Yet RecruitingNCT07327944
What this trial is testing

Relapse Management Group Psychoeducation Program

Who this might be right for
Relapse Management
Ankara Etlik City Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT01576640
What this trial is testing

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Who this might be right for
Nicotine DependenceSchizophrenia
Massachusetts General Hospital 17
Not applicableUnknownNCT00192582
What this trial is testing

AIMHI NT Relapse Prevention Trial

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychoses, Substance Induced+2 more
Menzies School of Health Research 90
Large-scale testing (Phase 3)Study completedNCT01412060
What this trial is testing

Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 765
Large-scale testing (Phase 3)Study completedNCT00283179
What this trial is testing

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Taiwan Otsuka Pharm. Co., Ltd 83
Post-approval studies (Phase 4)Ended earlyNCT05662306
What this trial is testing

C-Cog in Early Course Schizophrenia Study

Who this might be right for
Schizophrenia
University of Miami 1
Not applicableStudy completedNCT01202617
What this trial is testing

Seroquel XR in the Long Term Treatment of Schizophrenia

Who this might be right for
Relapse in Schizophrenia
AstraZeneca 1,606
Testing effectiveness (Phase 2)Study completedNCT01214005
What this trial is testing

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Who this might be right for
Tobacco Use DisorderSchizophrenia
Brown University 60
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Not applicableUnknownNCT03248180
What this trial is testing

Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States

Who this might be right for
PsychosisRemission
National Taiwan University Hospital 160
Post-approval studies (Phase 4)Study completedNCT00621777
What this trial is testing

Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
Massachusetts General Hospital 247
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Not applicableStudy completedNCT02224430
What this trial is testing

Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Alabama at Birmingham 40
Post-approval studies (Phase 4)Ended earlyNCT04203056
What this trial is testing

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Who this might be right for
SchizophreniaSchizoaffective Disorder, Depressive TypeSchizophreniform Disorder
University of California, Los Angeles 15
Not applicableLooking for participantsNCT06613334
What this trial is testing

Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses

Who this might be right for
Schizophrenia
Centre Hospitalier St Anne 200
Not applicableStudy completedNCT03019887
What this trial is testing

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Who this might be right for
Schizophrenia Relapse
Juntendo University 139
Large-scale testing (Phase 3)Study completedNCT00216476
What this trial is testing

Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag International NV 753
Post-approval studies (Phase 4)Study completedNCT02307396
What this trial is testing

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Who this might be right for
SchizophreniaSchizophrenia and Disorders With Psychotic FeaturesSchizoaffective Disorders
Technical University of Munich 21
Not applicableLooking for participantsNCT06978894
What this trial is testing

Predicting Psychotic Relapse Using Speech-Based Early Detection

Who this might be right for
Psychosis
Douglas Mental Health University Institute 250
Next Page